SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-11-000051
Filing Date
2011-02-11
Accepted
2011-02-10 18:53:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC 13G ANNUAL 2010 cpix1210.txt SC 13G/A 7092
  Complete submission text file 0000053417-11-000051.txt   9034
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 11594247
SIC: 2834 Pharmaceutical Preparations